Sabine Druillennec

Sabine Druillennec

Auto-generated profile, based on publicly available information

Sabine Druillennec

Institut Curie, Orsay, France

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2000 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
EJEtienne D JACOTOT
Etienne D JACOTOT
LRLuigi Ravagnan
Luigi Ravagnan
MLMarkus Loeffler
Markus Loeffler
KFKarine F. Ferri
Karine F. Ferri
Helena L.A. VieiraHelena L.A. Vieira
Helena L.A. Vieira
Guido KroemerGuido Kroemer
Guido Kroemer
Viral protein R (Vpr) encoded by HIV-1 is a facultative inducer of apoptosis. When added to intact cells or purified mitochondria, micromolar and submicromolar doses of synthetic Vpr cause a rapid dissipation of the mitochondrial transmembrane potential (ΔΨm), as well as the mitochondrial release of apoptogenic proteins such as cytochrome c or apoptosis inducing factor. The same structural motifs relevant for cell killing are responsible for the mitochondriotoxic effects of Vpr. Both mitochondrial and cytotoxic Vpr effects are prevented by Bcl-2, an inhibitor of the permeability transition pore complex (PTPC). Coincubation of purified organelles revealed that nuclear apoptosis is only induced by Vpr when mitochondria are present yet can be abolished by PTPC inhibitors. Vpr favors the permeabilization of artificial membranes containing the purified PTPC or defined PTPC components such as the adenine nucleotide translocator (ANT) combined with Bax. Again, this effect is prevented by addition of recombinant Bcl-2. The Vpr COOH terminus binds purified ANT, as well as a molecular complex containing ANT and the voltage-dependent anion channel (VDAC), another PTPC component. Yeast strains lacking ANT or VDAC are less susceptible to Vpr-induced killing than control cells yet recover Vpr sensitivity when retransfected with yeast ANT or human VDAC. Hence, Vpr induces apoptosis via a direct effect on the mitochondrial PTPC.

29 October 2018 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MCMichael CEREZO
Michael CEREZO
RGRamdane Guemiri
Ramdane Guemiri
SDSabine Druillennec
Sabine Druillennec
IGIsabelle Girault
Isabelle Girault
HMHélène Malka-Mahieu
Hélène Malka-Mahieu
Caroline RobertCaroline Robert
Caroline Robert

19 February 2001 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
EJEtienne D JACOTOT
Etienne D JACOTOT
KFKarine F. Ferri
Karine F. Ferri
CHChahrazed El Hamel
Chahrazed El Hamel
CBCatherine Brenner
Catherine Brenner
SDSabine Druillennec
Sabine Druillennec
Guido KroemerGuido Kroemer
Guido Kroemer
Viral protein R (Vpr), an apoptogenic accessory protein encoded by HIV-1, induces mitochondrial membrane permeabilization (MMP) via a specific interaction with the permeability transition pore complex, which comprises the voltage-dependent anion channel (VDAC) in the outer membrane (OM) and the adenine nucleotide translocator (ANT) in the inner membrane. Here, we demonstrate that a synthetic Vpr-derived peptide (Vpr52-96) specifically binds to the intermembrane face of the ANT with an affinity in the nanomolar range. Taking advantage of this specific interaction, we determined the role of ANT in the control of MMP. In planar lipid bilayers, Vpr52-96 and purified ANT cooperatively form large conductance channels. This cooperative channel formation relies on a direct protein–protein interaction since it is abolished by the addition of a peptide corresponding to the Vpr binding site of ANT. When added to isolated mitochondria, Vpr52-96 uncouples the respiratory chain and induces a rapid inner MMP to protons and NADH. This inner MMP precedes outer MMP to cytochrome c. Vpr52-96–induced matrix swelling and inner MMP both are prevented by preincubation of purified mitochondria with recombinant Bcl-2 protein. In contrast to König9s polyanion (PA10), a specific inhibitor of the VDAC, Bcl-2 fails to prevent Vpr52-96 from crossing the mitochondrial OM. Rather, Bcl-2 reduces the ANT–Vpr interaction, as determined by affinity purification and plasmon resonance studies. Concomitantly, Bcl-2 suppresses channel formation by the ANT–Vpr complex in synthetic membranes. In conclusion, both Vpr and Bcl-2 modulate MMP through a direct interaction with ANT.

1 August 2002 in The EMBO Journal
Verified
Journal Article
Closed access
PDF file
MCMaria Castedo
Maria Castedo
TRThomas Roumier
Thomas Roumier
JBJulià Blanco
Julià Blanco
KFKarine F. Ferri
Karine F. Ferri
JBJordi Barretina
Jordi Barretina
Guido KroemerGuido Kroemer
Guido Kroemer

1 January 2012 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
JAJean Philippe Arnault
Jean Philippe Arnault
CMChristine Mateus
Christine Mateus
BEBernard Escudier
Bernard Escudier
GTGorana Tomasic
Gorana Tomasic
JWJanine Wechsler
Janine Wechsler
Caroline RobertCaroline Robert
Caroline Robert
Purpose: The emergence of skin tumors in patients treated with sorafenib or with more recent BRAF inhibitors is an intriguing and potentially serious event. We carried out a clinical, pathologic, and molecular study of skin lesions occurring in patients receiving sorafenib.

1 October 2010 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
ICIsabelle Coste
Isabelle Coste
KCKaty Le Corf
Katy Le Corf
AKAlain Kfoury
Alain Kfoury
IHIsabelle Hmitou
Isabelle Hmitou
SDSabine Druillennec
Sabine Druillennec
TRToufic Renno
Toufic Renno
Accumulating evidence points to inflammation as a promoter of carcinogenesis. MyD88 is an adaptor molecule in TLR and IL-1R signaling that was recently implicated in tumorigenesis through proinflammatory mechanisms. Here we have shown that MyD88 is also required in a cell-autonomous fashion for RAS-mediated carcinogenesis in mice in vivo and for MAPK activation and transformation in vitro. Mechanistically, MyD88 bound to the key MAPK, Erk, and prevented its inactivation by its phosphatase, MKP3, thereby amplifying the activation of the canonical RAS pathway. The relevance of this mechanism to human neoplasia was suggested by the finding that MyD88 was overexpressed and interacted with activated Erk in primary human cancer tissues. Collectively, these results show that in addition to its role in inflammation, MyD88 plays what we believe to be a crucial direct role in RAS signaling, cell-cycle control, and cell transformation.